Brian Mueller, CPA

Chief Financial Officer

Professional Overview

Brian Mueller is a seasoned financial executive with over 20 years of experience in the biotechnology industry. As the Chief Financial Officer of BioMarin Pharmaceutical Inc., he oversees all aspects of the company's financial operations, including accounting, treasury, tax, investor relations, and strategic planning. Mr. Mueller's deep expertise in financial management, coupled with his strong leadership skills, have been instrumental in driving the company's continued growth and success.

Experience Summary

Current Role

Mr. Mueller has served as the Chief Financial Officer of BioMarin Pharmaceutical Inc. since February 2020. In this role, he is responsible for managing the company's financial resources, ensuring compliance with regulatory requirements, and supporting the strategic decision-making process. Under his leadership, BioMarin has maintained a robust financial position, successfully navigated complex regulatory landscapes, and strengthened its position as a leading global biotechnology company.

Career Progression

Prior to his current role, Mr. Mueller held various senior finance positions at BioMarin Pharmaceutical Inc., including Senior Vice President, Finance & Chief Accounting Officer from 2002 to 2020. In this capacity, he played a pivotal role in the company's financial reporting, internal controls, and operational efficiency initiatives. Earlier in his career, Mr. Mueller gained valuable experience as a Senior Manager in the Audit practices of Arthur Andersen and KPMG, where he provided financial advisory services to clients in the biotechnology and pharmaceutical industries.

Academic Background

Mr. Mueller holds a Bachelor of Science degree in Accounting from the University of Illinois at Urbana-Champaign. He is a Certified Public Accountant (CPA) and has continuously maintained his professional certifications throughout his career.

Areas of Expertise

• Financial management and strategic planning

• Regulatory compliance and financial reporting

• Mergers, acquisitions, and integration

• Investor relations and capital market transactions

• Leadership and team development

Professional Impact

Under Mr. Mueller's financial stewardship, BioMarin Pharmaceutical Inc. has achieved significant milestones, including the successful commercialization of multiple rare disease therapies, the expansion of its global footprint, and the implementation of robust internal controls and risk management frameworks. His strategic vision and analytical expertise have been instrumental in securing the company's long-term financial stability and positioning it for continued growth and innovation.

Conclusion

With his extensive experience, deep industry knowledge, and proven track record of financial and operational excellence, Brian Mueller is a highly valued member of the BioMarin Pharmaceutical Inc. leadership team. His commitment to driving sustainable growth and creating long-term shareholder value makes him an invaluable asset to the organization.